Loading page…
Healthcare
Twist Bioscience Corporation achieves an AlphaScore of 44/100, carrying a neutral grade of C in the healthcare sector as of October 11, 2026. Key metrics include a gross margin of 50.72% and a net margin of -20.63%. Among its operational indicators, a distinct strength is its high growth sub-score of 91, paired with a 20.32% revenue growth rate. A notable risk is its negative return on equity of -16.42% and a negative forward PE of -212.59, highlighting persistent bottom-line pressures. Evidence is strictly limited to the supplied dataset.
Written 11/10/2026, 00:38:35 UTC · Snapshot 11/10/2026